Month: February 2022

Figure 1 Alaska Project Location Map. Current projects have gold marker. Former projects have black marker.Figure 2 Project locations in which Millrock has ownership and / or royalty interests.Key Highlights – Anticipated 2022 Activity:Drilling on at least four and perhaps as many as eight projects in which Millrock has equity and royalty interests.Treasure Creek, Ester, Fairbanks district, Liberty Bell gold projects, Fairbanks area, Alaska (Felix Gold 15,000 meters planned). 64North gold project, Pogo Mine area, Alaska (Resolution Minerals, planning in progress). Apex El Nido gold project, southeast Alaska (Coeur Explorations, 1,500 meters under consideration). Batamote copper project, Sonora Mexico (Mine Discovery Fund earning in, preliminary planning in progress). El Picacho gold project, Sonora Mexico (Tocvan Ventures, preliminary...

Delivers security, operational efficiency, and cost benefits unmatched by traditional identity frameworks Atlanta , Feb. 24, 2022 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID), the Privacy-First Identity CompanyTM providing AI-powered trust and identity services used globally across multiple sectors, announces the launch of its end-to-end Identity Orchestration Platform, which streamlines delivery and implementation of the Company’s proven technologies through a low-code approach. Trust Stamp’s powerful identity platform enables clients to transform security, privacy, and usability in digital operations with a range of leading AI-powered technologies including biometric, document and liveness verification, as well as data-protection and more, in order to support robust identity frameworks that can be established,...

Ceremony Recognizes Importance of Biopharma Industry and Advocacy Group Collaboration to Address Needs for New Treatments in Orphan and Rare Disorders Together, Will Ring the Nasdaq Opening Bell to Kick-Off Rare Disease Day on February 28, 2022 CORAL GABLES, Fla., Feb. 24, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today announced that the company is standing with the National Organization for Rare Disorders (NORD), Global Genes, Muscular Dystrophy Association, Myasthenia Gravis Foundation of America, Conquer MG, and Myasthenia Gravis Association, to ring the opening bell of the Nasdaq market on international...

SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present virtually at the 42nd Annual Cowen Healthcare Conference on Wednesday, March 9th at 2:10 pm Eastern time / 11:10 am Pacific Time. Additionally, Todd will participate in a ‘Synthetic Biology Enabling Technologies Panel’ on Monday, March 7th at 10:30 am Eastern time / 7:30 am Pacific Time. The presentation and panel discussion will both be webcast live and can be accessed through a link on the investors section of Codex DNA’s website at https://ir.codexdna.com. An archived replay of each webcast will be available for 30 days following the event. About Codex DNACodex DNA is empowering scientists with the ability...

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, will participate in the following conferences in March.Cowen 42nd Annual Health Care Conference: Dr. Coulie will participate in the Respiratory/ Infections panel on Tuesday, March 8, at 2:10 p.m. ET / 11:10 a.m. PT Oppenheimer 32nd Annual Healthcare Conference: Dr. Coulie will present a company update on Wednesday, March 16, at 3:20 p.m. ET / 12:20 p.m. PTInterested parties can access these presentations from the Investor Relations’ Events & Presentation page of Pliant’s website at https://ir.pliantrx.com/news-and-events/events-and-presentations...

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 24 FEBRUARY 2022 AT 15.01 P.M. EET, OTHER INFORMATION DISCLOSED TO THE RULES OF THE EXCHANGEOma Savings Bank Plc’s Board of Directors decided on a new incentive scheme and an earning period for key persons for 2022-2023 The Board of Directors of Own Savings Bank Plc (OmaSp or the Company) has decided to establish a new share-based incentive scheme for key persons of the Group. The aim of the scheme is to combine the interests of owners and key persons in order to increase the value of the Company in the long term, and to commit the key persons to implement the Company’s strategy, objectives and long-term interest and to provide them with competitive earnings of the Company’s shares and a remuneration scheme based on accrual. The share-based incentive scheme is in place until...